Exchanges will suspend the trading of GlaxoSmithKline Consumer Healthcare from April 16 (also ex-date) following its scheme of arrangement with Hindustan Unilever, according to a release by the exchanges.
Shareholders of GSK Consumer will receive 4.39 shares of Hindustan Unilever for every share held in the company
As per the deal, GSK Plc (parent) will own 5.7 per cent of the merged entity, but will have no representation on the board after the merger. Currently, 27.54 per cent stake of Glaxo Consumer is held by the public.
Shares of GSK Consumer on Wednesday closed a tad higher at ₹10,645.45 on BSE, while those of HUL gained 0.9 per cent at ₹2,466.40.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.